Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3019 Target Snapshot

Cytochrome P450 3A5 · SINGLE PROTEIN · Homo sapiens

262Compounds
271Assays
11Approved Drugs
129.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P20815. Use UniProt P20815 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P20815 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 3A5 as ChEMBL target CHEMBL3019, mapped to UniProt P20815. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 3A5
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3019
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P20815
Cytochrome P450 3A5
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 3A5 is the right protein anchor across sources, using UniProt P20815 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 3A5
UniProt AccessionP20815
Component TypeProtein
Sequence Length502 aa

Cytochrome P450 3A5

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 3A5, mapped to UniProt P20815. Sequence length is 502 aa.

Mapped IDP20815
Review nameCytochrome P450 3A5
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

11
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50115.0
KI12.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1159650 7.68 IC50 21.0 Approved
CHEMBL1159650 7.0 Kd 100.0 Approved
CHEMBL157101 6.92 IC50 120.0 Approved
CHEMBL163 6.92 Ki 120.0 Approved
CHEMBL269732 6.85 IC50 140.0 Approved
CHEMBL190461 6.72 Ki 190.0 Approved
CHEMBL116 6.7 Ki 200.0 Approved
CHEMBL3422028 6.25 IC50 556.0 Preclinical
CHEMBL584 6.24 Ki 570.0 Approved
CHEMBL2386285 6.14 IC50 723.0 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
7
5.5
10
6.0
9
6.5
3
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CANNABIDIOL
CHEMBL190461
Approved 2018
AMPRENAVIR
CHEMBL116
Approved 1999
NELFINAVIR
CHEMBL584
Approved 1997
RITONAVIR
CHEMBL163
Approved 1996
TACROLIMUS ANHYDROUS
CHEMBL269732
Approved 1994
CLOBETASOL PROPIONATE
CHEMBL1159650
Approved 1985
KETOCONAZOLE
CHEMBL157101
Approved 1981
Assay Landscape

Assay Landscape

272
Total Assays
42
Tested Compounds
2
Assay Types
ADME — 257 assays, 42 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 162 38 5.1
assay format 49 3 6.2
microsome format 23 0
cell-based format 17 1 6.7
tissue-based format 6 0
Binding — 15 assays, 7 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 7 2 5.8
cell-based format 4 2 6.9
microsome format 2 0
single protein format 2 3 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine